| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Climb Bio, Inc. (CLYM) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. CLYM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 22.55M | $256.35M | - | |
| CEO | 700.0K | $7.96M | - | |
| Dir | 304.7K | $3.46M | - | |
| Other | 300.0K | $3.41M | - | |
| CFO | 142.5K | $1.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | Morisset Valerie93 | EVP, R&D And CSO | Sell | 92,377 | $7.04 | $650,562.77 | -14.4% | -22.2% | -80.4% | |
| Jul 11, 2024 | Morisset Valerie93 | EVP, R&D And CSO | Sell | 105,931 | $6.95 | $736,500.46 | -8.2% | -27.0% | -80.6% | |
| Jul 5, 2024 | Morisset Valerie93 | EVP, R&D And CSO | Sell | 12,342 | $7.06 | $87,134.52 | -2.7% | -23.1% | -81.0% | |
| Jul 3, 2024 | Morisset Valerie93 | EVP, R&D And CSO | Sale+OE | 50,000 | $6.76 | $338,000.00 | -9.7% | -24.8% | -81.3% | |
| Jun 27, 2024 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 13,008,546 | $3.84 | $49,952,816.64 | +97.2% | -27.0% | -84.3% | |
| Jun 20, 2024 | Pimblett Emily53 | Chief Accounting Officer | Sale+OE | 1,245 | $7.21 | $8,982.05 | -24.9% | +3.0% | -84.4% | |
| Aug 12, 2021 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 3,200,000 | $12.50 | $40,000,000.00 | +40.6% | -1.0% | -83.0% | |
| Aug 12, 2021 | Ai Eti LLC | 10% Owner | Buy | 800,000 | $12.50 | $10,000,000.00 | +19.0% | -1.0% | -83.0% |